157 related articles for article (PubMed ID: 22750187)
21. Brain metastases in breast cancer.
Sim HW; Morris PG; Patil S; Khasraw M
Expert Rev Anticancer Ther; 2014 Feb; 14(2):173-83. PubMed ID: 24308683
[TBL] [Abstract][Full Text] [Related]
22. Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article.
Salvetti DJ; Nagaraja TG; McNeill IT; Xu Z; Sheehan J
J Neurosurg; 2013 Jun; 118(6):1250-7. PubMed ID: 23540265
[TBL] [Abstract][Full Text] [Related]
23. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
24. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
25. [Global brain metastases management strategy: a multidisciplinary-based approach].
Métellus P; Tallet A; Dhermain F; Reyns N; Carpentier A; Spano JP; Azria D; Noël G; Barlési F; Taillibert S; Le Rhun É
Cancer Radiother; 2015 Feb; 19(1):61-5. PubMed ID: 25649388
[TBL] [Abstract][Full Text] [Related]
26. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
27. Metastases to the brain: current management perspectives.
Nathoo N; Toms SA; Barnett GH
Expert Rev Neurother; 2004 Jul; 4(4):633-40. PubMed ID: 15853582
[TBL] [Abstract][Full Text] [Related]
28. Multimodality management of non-small cell lung cancer patients with brain metastases.
Ricciardi S; de Marinis F
Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
[TBL] [Abstract][Full Text] [Related]
29. Brain metastases in patients with breast cancer: new horizons.
Kirsch DG; Loeffler JS
Clin Breast Cancer; 2005 Jun; 6(2):115-24. PubMed ID: 16001989
[TBL] [Abstract][Full Text] [Related]
30. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
31. [A case of effective paclitaxel therapy for adriamycin resistant metastatic breast cancer with brain metastases].
Kokufu I; Tanei T; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
Gan To Kagaku Ryoho; 2002 Apr; 29(4):585-8. PubMed ID: 11977543
[TBL] [Abstract][Full Text] [Related]
32. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
Suh JH; Stea B; Nabid A; Kresl JJ; Fortin A; Mercier JP; Senzer N; Chang EL; Boyd AP; Cagnoni PJ; Shaw E
J Clin Oncol; 2006 Jan; 24(1):106-14. PubMed ID: 16314619
[TBL] [Abstract][Full Text] [Related]
33. Brain metastases of breast cancer.
Melisko ME; Kunwar S; Prados M; Berger MS; Park JW
Expert Rev Anticancer Ther; 2005 Apr; 5(2):253-68. PubMed ID: 15877523
[TBL] [Abstract][Full Text] [Related]
34. Systemic treatment in breast-cancer patients with brain metastasis.
Arslan C; Dizdar O; Altundag K
Expert Opin Pharmacother; 2010 May; 11(7):1089-100. PubMed ID: 20345334
[TBL] [Abstract][Full Text] [Related]
35. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
[TBL] [Abstract][Full Text] [Related]
36. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes?
Park BB; Uhm JE; Cho EY; Choi YL; Ji SH; Nam DH; Lee JI; Park W; Huh SJ; Park YH; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2009 Mar; 63(4):627-33. PubMed ID: 18553084
[TBL] [Abstract][Full Text] [Related]
38. Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature.
Platta CS; Khuntia D; Mehta MP; Suh JH
Am J Clin Oncol; 2010 Aug; 33(4):398-407. PubMed ID: 19675447
[TBL] [Abstract][Full Text] [Related]
39. [Brain metastases from breast cancer: usefulness and limits of prognostic scores].
Le Scodan R; Massard C; Jouanneau L; Gutierrez M; Mouret-Fourme E
Bull Cancer; 2011 Apr; 98(4):377-84. PubMed ID: 21540138
[TBL] [Abstract][Full Text] [Related]
40. Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.
Charpentier MM
Ann Pharmacother; 2005 Dec; 39(12):2038-45. PubMed ID: 16249270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
